Diffuse large B-cell lymphoma that develops after adalimumab using adalimumab in a patient with psoriasis
Psoriasis is a polygenic, systemic inflammatory disease seen in 2% to 3% of the population and leads to a serious deterioration in the quality of life. As a result, studies on the pathophysiology of this disease have led to the development of cytokine-targeted therapies, especially the widespread us...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2021-06-01
|
Series: | Turkderm Turkish Archives of Dermatology and Venereology |
Subjects: | |
Online Access: | https://journal.turkderm.org.tr/jvi.aspx?pdir=turkderm&plng=eng&un=TURKDERM-34356&look4= |